Answers are grounded in this paper and cite their sources.
OBJECTIVE Posthemorrhagic hydrocephalus (PHH) is the leading neurosurgical complication of preterm intraventricular hemorrhage, yet ventriculoperitoneal shunt failure rates in this population remain disproportionately high and poorly understood. Abnormal cerebrospinal fluid (CSF) composition following hemorrhage has been proposed as a key contributor to shunt obstruction, but the clinical relevance of CSF biochemical and flow-related factors has not been systematically evaluated. This review evaluated whether CSF composition or flow dynamics predict shunt performance in neonates with PHH. METHODS A systematic review was conducted in accordance with the PRISMA 2020 guidelines and prospectively registered on PROSPERO (CRD420250642742). PubMed, MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched from database inception to June 2025. Studies involving neonates directly evaluating CSF parameters in relation to shunt outcomes were included for outcome synthesis; mechanistic, biomarker, and indirect clinical studies were incorporated separately as contextual evidence to support biological plausibility. A narrative synthesis was performed owing to clinical and methodological heterogeneity. Risk of bias was assessed using the ROBINS-I tool. RESULTS Direct clinical evidence linking CSF composition or flow-related factors to shunt performance in neonatal PHH is critically limited. Thirty-one studies met the inclusion criteria across 4 evidence tiers. Three studies directly related CSF parameters, or a CSF-directed intervention, to shunt outcomes. CSF protein was directly measured in only 1 of these studies and did not predict shunt failure. CSF infection was the strongest clinical predictor of shunt failure. No neonatal study directly measured CSF flow dynamics in relation to shunt outcomes. A broader mechanistic literature has demonstrated that PHH CSF is characterized by markedly elevated inflammatory mediators, growth factors, iron metabolites, and cellular debris, supporting the biological plausibility of CSF-driven shunt obstruction. CONCLUSIONS Despite compelling biological rationale, direct clinical evidence linking CSF composition or flow-related factors to shunt performance in neonatal PHH is critically limited. Elevated CSF protein may reflect hemorrhagic burden but does not reliably predict shunt failure as a standalone parameter. These findings do not support the use of CSF biomarker thresholds to guide clinical decision-making at this time. Prospective multicenter studies incorporating serial CSF biomarker profiling and direct flow measurements are needed to determine whether CSF-based predictors can meaningfully inform shunt management.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: